Unspecified Filariasis
ICD-10 B64 is a billable code used to indicate a diagnosis of unspecified filariasis.
Unspecified filariasis refers to a parasitic infection caused by filarial worms, which are transmitted to humans through the bites of infected mosquitoes. The condition is often associated with tropical and subtropical regions, where the vectors thrive. The most common filarial infections include lymphatic filariasis, which can lead to severe lymphedema and elephantiasis, and onchocerciasis, which can cause river blindness. Symptoms may vary widely, ranging from asymptomatic to severe manifestations, including swelling, pain, and skin changes. Diagnosis typically involves serological tests or identification of microfilariae in blood samples. Treatment protocols may include antiparasitic medications such as diethylcarbamazine (DEC) or ivermectin, depending on the specific type of filariasis. Management also focuses on alleviating symptoms and preventing secondary infections. Due to the complexity of the disease and its varied presentations, accurate coding is essential for appropriate treatment and reimbursement.
Detailed patient history, symptom description, diagnostic test results, and treatment plans.
Patients presenting with swelling, pain, or skin changes in endemic areas.
Ensure accurate documentation of travel history and exposure to vectors.
Comprehensive evaluation of symptoms, travel history, and potential exposure to filarial vectors.
Patients with chronic symptoms suggestive of filariasis in endemic regions.
Consider co-infections and other tropical diseases in differential diagnosis.
Used when testing for filariasis in symptomatic patients.
Document the reason for testing and any relevant symptoms.
Infectious disease specialists should ensure comprehensive evaluation.
Unspecified filariasis is primarily caused by filarial worms transmitted through mosquito bites, leading to various clinical manifestations.
Diagnosis typically involves clinical evaluation, serological tests, and identification of microfilariae in blood samples.
Treatment may include antiparasitic medications such as diethylcarbamazine (DEC) or ivermectin, along with supportive care for symptoms.
